ImmuneVax adheres to the continuous use of best practices in project management in the pharmaceutical, biotechnology, medical device and diagnostics industries.

Our solid knowledge of project management processes and methodology is critical to accentuating your preclinical project success.

At the outset, we gain a detailed understanding of your preclinical development process needs.

This includes transitioning from discovery to the preclinical phase, developing the target profile plan (TPP) and preclinical critical path, forming teams and developing budgets.

We only use good laboratory practices (GLP), a mode of practice that is sure to accelerate an investigational new drug application (IND) filing.

Efficient Project Management promotes the likelihood of successful commercialization of Life Sciences products. Understanding how to define your project’s scope and identify the critical resources needed for successful commercialization, is imperative. We may also facilitate outsourcing via a clinical research organization (CRO) partnering, and determine project and procurement costs, and even devise risk mitigation and and risk management plans. We take a lead role to establish quality monitoring and process controls, both to support our own Project Management activities, as well as those of select CROs.

Our requisite project management tools and techniques enhance our abilities to direct global projects. Further, our working knowledge of global clinical regulations permits us to manage resources across borders.

For Project Management in Clinical Development, ImmuneVax will apply sound project management processes to the design, planning and phases of clinical development. Our working teams start by developing a project management plan, including Good Clinical Practices (GCP) and standard operating procedures (SOP)–compliant project operating guidelines. This includes best clinical data-management practices, and identification and management of risks such as protocol deviation and adverse event reporting.

Industry sponsored research

ImmuneVax can identify, negotiate and set up Industry-sponsored research programs designed to maximize the benefits of your industry-academic research collaborations, to support your translational research, and accelerate the commercialization of promising products and services.

Grant sponsored research

ImmuneVax scientists have applied for and been awarded research grants ranging in value from $25,000 to $300 million. We have the potential to obtain grant funding from Government, Non-Government Organizations, and the Private Sector.